| è´§å· | å“牌 | 产å“åç§° | è§„æ ¼ | 包装ã€å‚è€ƒä»·æ ¼ | |
| F793680 | MACKLIN | 氟康唑 | 10mM in DMSO | 261元/1ml; | 咨询 |
储å˜ï¼š-20°C 状æ€ï¼šæ¶²ä½“ |
| F0677 | TCI | Fluconazole | >98.0%(GC)(T) | 300元/1G; 865元/5G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 纯度/åˆ†æžæ–¹æ³• | >98.0%(GC)(T) | | 分åå¼/分åé‡ | C13H12F2N6O = 306.28 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 4269710 | | PubChem物质ID | 87560996 | | Merck Index (14) | 4122 |
æŠ€æœ¯è§„æ ¼ | Appearance | White to Almost white powder to crystal | | Purity(GC) | min. 98.0 % | | Purity(Nonaqueous Titration) | min. 98.0 % | | Melting point | 138.0 to 142.0 ℃ |
物性(å‚考值) | 熔点 | 141 ℃ | | 溶解性(坿º¶äºŽ) | 甲醇 |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | ä¿¡å·è¯ | è¦å‘Š | | å±é™©æ€§è¯´æ˜Ž | H302 : åžå’½æœ‰å®³ã€‚ H315 : é€ æˆçš®è‚¤åˆºæ¿€ã€‚ H319 : é€ æˆä¸¥é‡çœ¼åˆºæ¿€ã€‚
| | 防范说明 | P501 : 将内装物/容器é€åˆ°æ‰¹å‡†çš„废物处ç†åނ处ç†ã€‚ P270 : ä½¿ç”¨æœ¬äº§å“æ—¶ä¸è¦è¿›é£Ÿã€é¥®æ°´æˆ–å¸çƒŸã€‚ P264 : 作业åŽå½»åº•清洗皮肤。 P280 : 戴防护手套/戴防护眼罩/戴防护é¢å…·ã€‚ P302 + P352 : 如皮肤沾染:用水充分清洗。 P337 + P313 : 如ä»è§‰çœ¼åˆºæ¿€ï¼šæ±‚医/就诊。 P305 + P351 + P338 : 如进入眼ç›ï¼šç”¨æ°´å°å¿ƒå†²æ´—å‡ åˆ†é’Ÿã€‚å¦‚æˆ´éšå½¢çœ¼é•œå¹¶å¯æ–¹ä¾¿åœ°å–出,å–出éšå½¢çœ¼é•œã€‚ç»§ç»å†²æ´—。 P362+P364 : 脱掉沾污的衣æœï¼Œæ¸…æ´—åŽæ–¹å¯é‡æ–°ä½¿ç”¨ã€‚ P332 + P313 : 如å‘生皮肤刺激:求医/就诊。 P301 + P312 + P330 : 如误åžå’½ï¼šå¦‚感觉ä¸é€‚ï¼Œå‘¼å«æ€¥æ•‘ä¸å¿ƒ/医生。漱å£ã€‚
|
相关法规 |
| 433638 | J&K | Fluconazole | 98.5% | 66元/250MG; 98元/1g; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 分åå¼ | C13H12F2N6O | | 分åé‡ | 306.28 | | 熔点 | 138-142 | | MDLç¼–ç | MFCD00274549 | | Beilstein | 4269710 | | Merck | 14,4122 |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | æç¤ºè¯ | Warning | | å±é™©è¯´æ˜Ž | H302 H315 H319 H335 | | 防范说明 | P261 P305+P351+P338 | | RTECS | XZ4810000 |
|
| F-097 | Supelco | Fluconazole solution | 10 mg/mL in ethanol, certified reference material, ampule of 1 mL, Cerilliant® | 3931.89å…ƒ/1 ML; | 咨询 |
产å“说明 一般æè¿° Fluconazole, sold under trade names such as Trican, Monicure, Diflucan®, and Afungil, is an antifungal drug used in the treatment and prevention of superficial and systemic fungal infections. This Certified Spiking Solution® is suitable as starting material for calibrators, controls, or linearity standards for therapeutic drug monitoring or clinical and diagnostic testing of fluconazole in patient blood, serum, or plasma samples by HPLC or LC-MS/MS. æ³•å¾‹ä¿¡æ¯ CERILLIANT is a registered trademark of Cerilliant Corporation CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation Diflucan is a registered trademark of Pfizer, Inc. Snap-N-Shoot is a registered trademark of Cerilliant Corporation Snap-N-Spike is a registered trademark of Cerilliant Corporation åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C13H12F2N6O | | 分åé‡ | 306.27 | | MDLç¼–å· | MFCD00274549 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 300 | | ç‰çº§ | certified reference material | | 特点 | Snap-N-Spike®/Snap-N-Shoot® | | 包装 | ampule of 1 mL | | manufacturer/tradename | Cerilliant® | | 浓度 | 10 mg/mL in ethanol | | æ ¼å¼ | single component solution | | å‚¨å˜æ¸©åº¦ | −20℃ | | InChI | 1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2 | | InChI key | RFHAOTPXVQNOHP-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |    | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H225 - H319 - H360D | | 预防措施声明 | P201 - P202 - P210 - P233 - P305 + P351 + P338 - P308 + P313 | | å±é™©åˆ†ç±» | Eye Irrit. 2 - Flam. Liq. 2 - Repr. 1B | | 储å˜åˆ†ç±»ä»£ç | 3 - Flammable liquids | | WGK | WGK 2 | | 闪点(F) | 55.4 °F | | 闪点(C) | 13 ℃ |
|
| Y0000558 | | Fluconazole for peak identification | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生ç†ä½œç”¨ æ°Ÿåº·å”‘æ˜¯ä¸€ç§æŠ—çœŸèŒå‰‚。是真èŒç»†èƒžè‰²ç´ P-450甾醇C-14α-åŽ»ç”²åŸºåŒ–çš„é«˜é€‰æ‹©æ€§æŠ‘åˆ¶å‰‚ã€‚æ°Ÿåº·å”‘æ˜¯ä¸€ç§æœ‰æ•ˆçš„CYP2C9抑制剂。氟康唑å¯å¹²æ‰°çœŸèŒéº¦è§’ç”¾é†‡åˆæˆå¹¶ä¸‹è°ƒé‡‘å±žç¡«è›‹ç™½åŸºå› ã€‚ 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. æ³¨æ„ Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C13H12F2N6O | | 分åé‡ | 306.27 | | MDLç¼–å· | MFCD00274549 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329831020 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | FC1=CC(F)=C(C(CN2N=CN=C2)(O)CN3N=CN=C3)C=C1 | | InChI | 1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2 | | InChI key | RFHAOTPXVQNOHP-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H302 - H360D - H412 | | 预防措施声明 | P201 - P202 - P264 - P273 - P301 + P312 - P308 + P313 | | å±é™©åˆ†ç±» | Acute Tox. 4 Oral - Aquatic Chronic 3 - Repr. 1B | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| F8929 | Sigma-Aldrich | Fluconazole | ≥98% (HPLC), powder | 2636.35å…ƒ/100 MG; | 咨询 |
产å“说明 一般æè¿° æ°Ÿåº·å”‘ç”¨äºŽæ²»ç–—ä¸æ€§ç»†èƒžå‡å°‘ç—‡æˆäººæ‚£è€…çš„ä¾µè¢æ€§å‡ä¸é…µæ¯èŒç—…(IC)。 应用 æ°Ÿåº·å”‘å·²ç”¨äºŽè¯„ä¼°æœ€ä½ŽæŠ‘èŒæµ“度(MIC)-çœŸèŒæ£€æµ‹ã€‚它还被用作æ¤ç‰©æŠ—çœŸèŒæ£€æµ‹çš„阳性对照。 包装 100 mg in glass bottle 生化/生ç†ä½œç”¨ æ°Ÿåº·å”‘æ˜¯ä¸€ç§æŠ—çœŸèŒå‰‚。是真èŒç»†èƒžè‰²ç´ P-450甾醇C-14α-åŽ»ç”²åŸºåŒ–çš„é«˜é€‰æ‹©æ€§æŠ‘åˆ¶å‰‚ã€‚æ°Ÿåº·å”‘æ˜¯ä¸€ç§æœ‰æ•ˆçš„CYP2C9抑制剂。氟康唑å¯å¹²æ‰°çœŸèŒéº¦è§’ç”¾é†‡åˆæˆå¹¶ä¸‹è°ƒé‡‘å±žç¡«è›‹ç™½åŸºå› ã€‚ 特点和优势 该化åˆç‰©ç”± Pfizerå¼€å‘。想æµè§ˆå…¶ä»–制è¯å…¬å¸å¼€å‘的化åˆç‰©å’Œå·²æ‰¹å‡†è¯ç‰©/候选è¯ç‰©ç›®å½•, 请å•击æ¤å¤„。 该化åˆç‰©æ˜¯ADME Toxç ”ç©¶çš„ç‰¹è‰²äº§å“。点击æ¤å¤„ 了解更多ADME Tox的特色产å“ã€‚äº†è§£æ›´å¤šæœ‰å…³ç”¨äºŽå…¶ä»–ç ”ç©¶é¢†åŸŸçš„ç”Ÿç‰©æ´»æ€§å°åˆ†å的信æ¯ï¼Œè¯·è®¿é—®sigma.com/discover-bsm。 其他说明 Scripps Center for Metabolomics(斯克里普斯代谢组å¦ä¸å¿ƒ)独立生æˆçš„串è”质谱数æ®ï¼Œå¯ä»¥PDFæ ¼å¼æŸ¥çœ‹æˆ–下载。F8929.pdf ç»è¿‡æµ‹è¯•的代谢物在Scripps Center for Metabolomics(斯克里普斯代谢组å¦ä¸å¿ƒ) METLIN代谢物数æ®åº“有é‡ç‚¹ä»‹ç»ã€‚更多信æ¯è¯·è§sigma.com/metlin。 åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C13H12F2N6O | | 分åé‡ | 306.27 | | MDLç¼–å· | MFCD00274549 | | PubChem化å¦ç‰©è´¨ç¼–å· | 24724485 | | NACRES | NA.77 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 100 | | 测定 | ≥98% (HPLC) | | å½¢å¼ | powder | | 溶解性 | DMSO: 5 mg/mL | | 作用机制 | enzyme | inhibits | | æŠ—ç”Ÿç´ æŠ—èŒè°± | fungi | | 创始人 | Pfizer | | å‚¨å˜æ¸©åº¦ | room temp | | SMILES string | FC1=CC(F)=C(C(CN2N=CN=C2)(O)CN3N=CN=C3)C=C1 | | InChI | 1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2 | | InChI key | RFHAOTPXVQNOHP-UHFFFAOYSA-N | | Gene Information | human ... CYP1A2(1544) |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H302 - H360D - H412 | | 预防措施声明 | P201 - P202 - P264 - P273 - P301 + P312 - P308 + P313 | | å±é™©åˆ†ç±» | Acute Tox. 4 Oral - Aquatic Chronic 3 - Repr. 1B | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
| PHR1160 | Supelco | Fluconazole | Pharmaceutical Secondary Standard; Certified Reference Material | 1359.83元/1 G; | 咨询 |
产å“说明 一般æè¿° ç”¨äºŽè´¨é‡æŽ§åˆ¶çš„åˆ¶è¯äºŒçº§æ ‡å‡†å“,å¯ä¸ºåˆ¶è¯å®žéªŒå®¤å’Œåˆ¶é€ 商æä¾›äº†ä¸€ç§æ–¹ä¾¿ä¸”ç»æµŽçš„æ›¿ä»£æ–¹æ¡ˆï¼Œç”¨äºŽå†…éƒ¨å·¥ä½œæ ‡å‡†å“的制备。 氟康唑是一ç§å¹¿è°±æŠ—èŒè¯ç‰©ã€‚用于å£è…”ã€é£Ÿç®¡ã€é˜´é“念ç èŒç—…åŠå…¶ä»–严é‡çš„系统性念ç èŒæ„ŸæŸ“的修å¤ã€‚该è¯å¯¹æ–°åž‹éšçƒèŒå¼•起的脑膜炎也有效。 应用 氟康唑å¯ç”¨ä½œè¯ç‰©å‚è€ƒæ ‡å‡†å“,通过色谱分æžå’Œåˆ†å…‰å…‰åº¦æµ‹å®šæŠ€æœ¯å¯¹åˆ¶è¯é…æ–¹ä¸çš„分æžç‰©è¿›è¡Œæµ‹å®šã€‚ è¿™äº›äºŒçº§æ ‡å‡†å“æ˜¯ç»è¿‡æ£€éªŒçš„è®¤è¯æ ‡å‡†ç‰©è´¨(CRM)。它们适用于多ç§åˆ†æžåº”用,包括但ä¸é™äºŽè¯ç‰©é‡Šæ”¾æµ‹è¯•ã€è¯ç‰©çš„定性和定é‡åˆ†æžæ–¹æ³•å¼€å‘ã€é£Ÿå“å’Œé¥®æ–™è´¨é‡æŽ§åˆ¶æ£€æµ‹ä»¥åŠå…¶ä»–æ ‡å®šåº”ç”¨ã€‚ 生化/生ç†ä½œç”¨ æ°Ÿåº·å”‘æ˜¯ä¸€ç§æŠ—çœŸèŒå‰‚。是真èŒç»†èƒžè‰²ç´ P-450甾醇C-14α-åŽ»ç”²åŸºåŒ–çš„é«˜é€‰æ‹©æ€§æŠ‘åˆ¶å‰‚ã€‚æ°Ÿåº·å”‘æ˜¯ä¸€ç§æœ‰æ•ˆçš„CYP2C9抑制剂。氟康唑å¯å¹²æ‰°çœŸèŒéº¦è§’ç”¾é†‡åˆæˆå¹¶ä¸‹è°ƒé‡‘å±žç¡«è›‹ç™½åŸºå› ã€‚ 分æžè¯´æ˜Ž è¿™äº›äºŒçº§æ ‡å‡†å“å¯è¿½æº¯è‡³USPã€EP(PhEur)å’ŒBPä¸€çº§æ ‡å‡†å“。 其他说明 分æžç‰©çš„æ•°å€¼åœ¨æ‰¹æ¬¡é—´å˜åŒ–很大。 è¯¥è®¤è¯æ ‡å‡†ç‰©è´¨(CRM)æ ¹æ®ISO 17034 å’Œ ISO/IEC 17025进行生产和认è¯ã€‚有关æ¤CRM使用的所有信æ¯å‡å¯åœ¨åˆ†æžè¯ä¹¦ä¸Šæ‰¾åˆ°ã€‚ 附注 è¦æŸ¥çœ‹è¯¥ææ–™çš„分æžè¯ä¹¦ç¤ºä¾‹ï¼Œè¯·åœ¨ä¸‹é¢çš„æ ä½ä¸è¾“å…¥LRAC0255ã€‚è¿™åªæ˜¯ä¸€ä¸ªç¤ºä¾‹è¯ä¹¦ï¼Œå¯èƒ½ä¸æ˜¯æ‚¨æ”¶åˆ°çš„æ‰¹æ¬¡ã€‚ åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C13H12F2N6O | | 分åé‡ | 306.27 | | MDLç¼–å· | MFCD00274549 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329823177 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | è´¨é‡æ°´å¹³ | 300 | | ç‰çº§ | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | è¯å…¸å¯è¿½æº¯æ€§ | traceable to BP 1174 traceable to PhEur Y0000557 traceable to USP 1271700 | | å‚¨å˜æ¸©åº¦ | 2-30℃ | | SMILES string | FC1=CC(F)=C(C(CN2N=CN=C2)(O)CN3N=CN=C3)C=C1 | | InChI | 1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2 | | InChI key | RFHAOTPXVQNOHP-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H302 - H360D - H412 | | 预防措施声明 | P201 - P202 - P264 - P273 - P301 + P312 - P308 + P313 | | å±é™©åˆ†ç±» | Acute Tox. 4 Oral - Aquatic Chronic 3 - Repr. 1B | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0000557 | | Fluconazole | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生ç†ä½œç”¨ æ°Ÿåº·å”‘æ˜¯ä¸€ç§æŠ—çœŸèŒå‰‚。是真èŒç»†èƒžè‰²ç´ P-450甾醇C-14α-åŽ»ç”²åŸºåŒ–çš„é«˜é€‰æ‹©æ€§æŠ‘åˆ¶å‰‚ã€‚æ°Ÿåº·å”‘æ˜¯ä¸€ç§æœ‰æ•ˆçš„CYP2C9抑制剂。氟康唑å¯å¹²æ‰°çœŸèŒéº¦è§’ç”¾é†‡åˆæˆå¹¶ä¸‹è°ƒé‡‘å±žç¡«è›‹ç™½åŸºå› ã€‚ 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. æ³¨æ„ Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C13H12F2N6O | | 分åé‡ | 306.27 | | MDLç¼–å· | MFCD00274549 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329831019 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | FC1=CC(F)=C(C(CN2N=CN=C2)(O)CN3N=CN=C3)C=C1 | | InChI | 1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2 | | InChI key | RFHAOTPXVQNOHP-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H302 - H360D - H412 | | 预防措施声明 | P201 - P202 - P264 - P273 - P301 + P312 - P308 + P313 | | å±é™©åˆ†ç±» | Acute Tox. 4 Oral - Aquatic Chronic 3 - Repr. 1B | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1271700 | USP | Fluconazole | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生ç†ä½œç”¨ æ°Ÿåº·å”‘æ˜¯ä¸€ç§æŠ—çœŸèŒå‰‚。是真èŒç»†èƒžè‰²ç´ P-450甾醇C-14α-åŽ»ç”²åŸºåŒ–çš„é«˜é€‰æ‹©æ€§æŠ‘åˆ¶å‰‚ã€‚æ°Ÿåº·å”‘æ˜¯ä¸€ç§æœ‰æ•ˆçš„CYP2C9抑制剂。氟康唑å¯å¹²æ‰°çœŸèŒéº¦è§’ç”¾é†‡åˆæˆå¹¶ä¸‹è°ƒé‡‘å±žç¡«è›‹ç™½åŸºå› ã€‚ 分æžè¯´æ˜Ž These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C13H12F2N6O | | 分åé‡ | 306.27 | | MDLç¼–å· | MFCD00274549 | | PubChem化å¦ç‰©è´¨ç¼–å· | 329749851 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | æ ¼å¼ | neat | | SMILES string | FC1=CC(F)=C(C(CN2N=CN=C2)(O)CN3N=CN=C3)C=C1 | | InChI | 1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2 | | InChI key | RFHAOTPXVQNOHP-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H302 - H360D - H412 | | 预防措施声明 | P201 - P202 - P264 - P273 - P301 + P312 - P308 + P313 | | å±é™©åˆ†ç±» | Acute Tox. 4 Oral - Aquatic Chronic 3 - Repr. 1B | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP1174 | | Fluconazole | British Pharmacopoeia (BP) Reference Standard | 2144.18元/100 MG; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生ç†ä½œç”¨ æ°Ÿåº·å”‘æ˜¯ä¸€ç§æŠ—çœŸèŒå‰‚。是真èŒç»†èƒžè‰²ç´ P-450甾醇C-14α-åŽ»ç”²åŸºåŒ–çš„é«˜é€‰æ‹©æ€§æŠ‘åˆ¶å‰‚ã€‚æ°Ÿåº·å”‘æ˜¯ä¸€ç§æœ‰æ•ˆçš„CYP2C9抑制剂。氟康唑å¯å¹²æ‰°çœŸèŒéº¦è§’ç”¾é†‡åˆæˆå¹¶ä¸‹è°ƒé‡‘å±žç¡«è›‹ç™½åŸºå› ã€‚ 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C13H12F2N6O | | 分åé‡ | 306.27 | | MDLç¼–å· | MFCD00274549 | | NACRES | NA.24 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | BP | | æ ¼å¼ | neat | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | FC1=CC(F)=C(C(CN2N=CN=C2)(O)CN3N=CN=C3)C=C1 | | InChI | 1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2 | | InChI key | RFHAOTPXVQNOHP-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H302 - H360D - H412 | | 预防措施声明 | P201 - P202 - P264 - P273 - P301 + P312 - P308 + P313 | | å±é™©åˆ†ç±» | Acute Tox. 4 Oral - Aquatic Chronic 3 - Repr. 1B | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP1175 | | Fluconazole impurity standard | British Pharmacopoeia (BP) Reference Standard | 1989元/50 MG; | 咨询 |
产å“说明 一般æè¿° This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生ç†ä½œç”¨ æ°Ÿåº·å”‘æ˜¯ä¸€ç§æŠ—çœŸèŒå‰‚。是真èŒç»†èƒžè‰²ç´ P-450甾醇C-14α-åŽ»ç”²åŸºåŒ–çš„é«˜é€‰æ‹©æ€§æŠ‘åˆ¶å‰‚ã€‚æ°Ÿåº·å”‘æ˜¯ä¸€ç§æœ‰æ•ˆçš„CYP2C9抑制剂。氟康唑å¯å¹²æ‰°çœŸèŒéº¦è§’ç”¾é†‡åˆæˆå¹¶ä¸‹è°ƒé‡‘å±žç¡«è›‹ç™½åŸºå› ã€‚ 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C13H12F2N6O | | 分åé‡ | 306.27 | | MDLç¼–å· | MFCD00274549 |
äº§å“æ€§è´¨ | ç‰çº§ | pharmaceutical primary standard | | manufacturer/tradename | BP | | æ ¼å¼ | mixture | | å‚¨å˜æ¸©åº¦ | 2-8℃ | | SMILES string | FC1=CC(F)=C(C(CN2N=CN=C2)(O)CN3N=CN=C3)C=C1 | | InChI | 1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2 | | InChI key | RFHAOTPXVQNOHP-UHFFFAOYSA-N |
å®‰å…¨ä¿¡æ¯ | 象形图 |   | | è¦ç¤ºç”¨è¯ï¼š | Danger | | å±é™©å£°æ˜Ž | H302 - H360D - H412 | | 预防措施声明 | P201 - P202 - P264 - P273 - P301 + P312 - P308 + P313 | | å±é™©åˆ†ç±» | Acute Tox. 4 Oral - Aquatic Chronic 3 - Repr. 1B | | 储å˜åˆ†ç±»ä»£ç | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 036566 | Fluorochem | 2,4-Difluoro-alpha,alpha-1-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol | 97% | 1584元/25g; 3960元/100g; 13860元/500g; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | CAS Number | 86386-73-4 | | MDL Number | MFCD00274549 | | Melting Point | 141℃ |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | å±é™©æ€§è¯´æ˜Ž | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P301 + P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: . P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see . on this label). P330: Rinse mouth. P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to local regulations.
|
|